2Doi SA Toers PA. Scott CJ. et al. PCOS. an ovarian disorder that leads to dysteguation in the hypothalamic -adrenal axis[ J]. Eur Obstet Gyneclol Reprod Biol, 2005,118 ( 1 ) :4
3Hanrdiman P Pillay os Atioma W Polycystic ovart syndrome and endometrial Carcinoma[ J]. Lancet. 2003. 361 (9371) : 1801.1802
5Blank SK. McCartney JC The origins and sequelac of abnormal neuroendocrine function in polycystic ovary syndrome [ J ] Hum Reprod Update. 2006,12(4) :351
6Sepilian V, Nagamani M. Effects of rosiglitazone in obese eomen with polyeystie ovary V, Nagamani M Effects of rosiglitar, ome in obese women with polyeystie ovary syndrome and severe insulin resistanee [J]. Clin Endocrin Metab,2005,90( 1 ) :60
7Erturk Kuru, Savci N. Serum leptin levels xorrelate with obesity parameters butnot with hyperinsulinism in women with polyeystie ovry syndrome[ J]. Fertil Sreril, 2004,82 (5) : 1364
8Ardaw MSM rouzi AA Plasma adipoectin and inslin reistance in women with polycystic ovary synerome [ J ]. Fertol Sreril, 2005,83 ( 6 ) : 1708
9Lee JH , Chan JL. Yiannakouris N , et al. Circulating resistin levels arenot associated with obesty or insulin resistance in humans snd are not regulated by fasting or leptin administration - cross - sectional and interventionalstudies in - normal, insulin - resistant and diabetic subijects[ J]. Clin Endocinol Metab ,2003,88(10) :4848
10Mendonca HC, Montenegro Junior RM. Foss MC, et al Positive correlation of serum leptin with estradiol levels in parients with polycystic ovary syndrome [ J ]. Braz J Med boil Res, 2004,37 ( 5 ) :729
二级参考文献46
1Kaaijk EM,Sasano H,Suzuki T,et al. Distribution of steroidogenic enzymes involved in androgen synthesis in polycystic ovaries: an immunohistochemical study.Mol Hum Reprod, 2000,6:443-447.
2Pirwany IR, Yates RW, Cameron IT, et al. Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhoea.Hum Reprod, 1999,14:2963-2968.
4Greenblatt E, Casper RF. Endocrine changes after laparoscopic ovarian cautery in polycystic ovarian syndrome. Am J Obstet Gynecol,1987,42:517-518.
5Rossmanith WG, Keckstein J, Spatzier K, et al. The impact of ovarian laser surgery on the gonadotrophin secretion in women with polycystic ovarian disease.Clin Endocrinol,1991,34:223-230.
6Sumioki H, Utsunomiya T. Ovarian drilling. In: Kempers R, Cohen J, Haney AF, et al, eds. Fertility and reproduction medicine. New York: Elsevier Science,1998.537-539.
7Tropeano G, Liberale I, Vuolo IP, et al. Effects of ovary suppression by a long-acting GnRH-agonist on circulating GH, insulin-like growth factor I and insulin levels in women with polycystic ovary syndrome. J Endocrinol Invest, 1997,20:220-224.
8Young RH. Dusting off old books: comments on classic gynecologic pathology books of yesteryear.Int J Gynecol Pathol, 2000,19:67-84.
9Ferraretti AP, Gianaroli L, Magli MC, et al. Transvaginal ovarian drilling: a new surgical treatment for improving the clinical outcome of assisted reproductive technologies in patients with polycystic ovary syndrome.Fertil Steril, 2001,76:812-816.
10Russell JB, Knezevich KM, Fabian KF,et al. Unstimulated immature oocyte retrieval: early versus midfollicular endometrial priming.Fertil Steril, 1997,67:616-620.
